The safety and efficacy of methylnaltrexone in pediatric oncology patients: A single center experience

20230 citationsJournal Article

Authors

Lauren Koranteng · Memorial Sloan Kettering Cancer Center

Audrey Mauguen · Memorial Sloan Kettering Cancer Center

Miriam Butler · Cooper Medical School of Rowan University

Shirley Qiong Yan · Memorial Sloan Kettering Cancer Center

Damani Taylor · Metropolitan Jewish Health System

Abstract

Methylnaltrexone appears safe in the pediatric population and produces bowel movements in more than a third of pediatric patients. It is a feasible and safe option for opioid induced constipation in pediatric patients.

Topics & Keywords

Gastrointestinal motility and disorders Pediatric Pain Management Techniques Anesthesia and Pain Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Oncology Pharmacy Practice

Volume 30, Issue 1, pp. 4-8

DOI: 10.1177/10781552231163540

Field-Weighted Citation Impact: 0.00